Notably, due to disruption of p53/pRb and cell cycle regulation caused by HPV infection, the proteins involved in cell cycle checkpoint activation, particularly CHK1 and WEE1 in the G2/M checkpoint, are of therapeutic interest in causing enhanced RT treatment of HPV-positive HNSCC. This evidence concerns the gene WEE1 and head and neck squamous cell carcinoma.